Oxford Financial Group LTD Corcept Therapeutics Inc Transaction History

Oxford Financial Group LTD

  • $1.51 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 10, 2021
SELL
$23.49 - $30.56 $4.86 Million - $6.33 Million
-206,982 Closed
0 $0
Q4 2020

Feb 10, 2021
SELL
$16.78 - $27.3 $2.19 Million - $3.56 Million
-130,454 Reduced 38.66%
206,982 $5.42 Million
Q3 2020

Nov 12, 2020
BUY
$12.46 - $19.98 $62,300 - $99,900
5,000 Added 1.5%
337,436 $5.87 Million
Q1 2020

May 12, 2020
BUY
$10.11 - $14.04 $3.36 Million - $4.67 Million
332,436 New
332,436 $3.95 Million

Others Institutions Holding CORT

# of Institutions
311
Shares Held
88.3M
Call Options Held
1.07M
Put Options Held
973K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $4.91B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Oxford Financial Group LTD Portfolio

Follow Oxford Financial Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxford Financial Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Oxford Financial Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email